One simple mission…to find you more time

Learn about our innovative drug delivery solution, ACT-IOP-003, a potential treatment for borderline resectable and non-resectable pancreatic cancer.

News & Insights

August 11, 2021

Advanced Chemotherapy Technologies, Inc. Awarded $4 Million NIH Grant to Pursue Treatment for Locally Advanced Non-resectable Pancreatic Cancer

November 1, 2020

November is Pancreatic Cancer Awareness Month

October 29, 2020

Advanced Chemotherapy Technologies, Inc. Announces $5.5M Series A Financing Round led by Khosla Ventures

June 30, 2020

Advanced Chemotherapy Technologies, Inc. Announces Issuance of US Patent for an Interventional Drug Delivery System

March 27, 2020

Advanced Chemotherapy Technologies, Inc. Files IND Application for First in Human use of ACT-IOP-003 in Pancreatic Cancer Patients

Advanced Chemotherapy Technologies, Inc.

111 James Jackson Avenue, Suite 131

Cary North Carolina 27513-3598

This website makes use of cookies. Please see our privacy policy for details.